MFSD2A c.469A>G ;(p.M157V)

Variant ID: 1-40430998-A-G

NM_032793.3(MFSD2A):c.469A>G;(p.M157V)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases.

Pharmaceutics
Nguyen, Huy H; Lee, Sung-Jin SJ; Li, Yang Y
Publication Date: 2022-11-16

Variant appearance in text: MFSD2A: M157V
PubMed Link: 36432666
Variant Present in the following documents:
  • Main text
View BVdb publication page



Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria.

American Journal Of Human Genetics
Pejaver, Vikas V; Byrne, Alicia B AB; Feng, Bing-Jian BJ; Pagel, Kymberleigh A KA; Mooney, Sean D SD; Karchin, Rachel R; O'Donnell-Luria, Anne A; Harrison, Steven M SM; Tavtigian, Sean V SV; Greenblatt, Marc S MS; Biesecker, Leslie G LG; Radivojac, Predrag P; Brenner, Steven E SE; ,
Publication Date: 2022-12-01

Variant appearance in text: rs764814462
PubMed Link: 36413997
Variant Present in the following documents:
  • mmc3.xlsx, sheet 1
View BVdb publication page